Effect of L-arginine on the microcirculation in the neuropathic diabetic foot in Type 2 diabetes mellitus: A double-blind, placebo-controlled study

Diabetic Medicine

Volumn 27, Issue 1, 2010, Pages 113-116

  Jude, E B ^a   Dang, C ^a   Boulton, A J M ^b  

^a TAMESIDE AND GLOSSOP INTEGRATED CARE NHS FOUNDATION TRUST   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Endothelial dysfunction; L arginine; Microcirculation

Indexed keywords

ARGININE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM; FEMALE; FOLLOW UP; HUMAN; MALE; MICROCIRCULATION; NEUROPATHY DISABILITY SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN TENSION; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VASODILATATION; VIBRATION PERCEPTION THRESHOLD;

ARGININE; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 73949134368     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02876.x     Document Type: Article

References (18)

1. Cotter MA, Cameron NE. The aetiopathogenesis of diabetic neuropathy: metabolic theories and vascular theories. In : Boulton AJM, ed. Diabetic Neuropathy. Carnforth, Lancashire : Marius Press, 1997 : 97 146.
2. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992 35 : 1011 1019.
3. Taylor PD, Graves JE, Poston L. Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci (Colch) 1995 88 : 519 524.
4. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Inves 1994 94 : 853 859.
5. Stevens MJ, Feldman EL, Greene DA. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med 1995 12 : 566 579.
6. Jude EB, Boulton AJM, Ferguson MWJ, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999 42 : 748 757.
7. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998 47 : 457 463.
8. Morris SM Jr. Arginine synthesis, metabolism, and transport: regulators of nitric oxide synthesis. In : Laskin JD, Laskin DL, eds. Cellular and Molecular Biology of Nitric Oxide. New York : Marcel Dekker, 1999 : 57 85.
9. La Civita L, Rossi M, Vagheggini G, Storino FA, Credidio L, Pasero G et al. Microvascular involvement in the systemic sclerosis: laser Doppler evaluation of reactivity to actetycholine and sodium nitroprusside by iontophoresis. Ann Rheum Dis 1998 57 : 52 55.
10. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997 95 : 1783 1790.
11. Mullen MJ, Wright D, Donald AE, Thorne S, Thomson H, Deanfield JE. Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Col Cardiol 2000 36 : 410 416.
12. Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 1998 32 : 110 116.
13. Kabat A, Dhein S. L-arginine supplementation prevents the development of endothelial dysfunction in hyperglycaemia. Pharmacology 2006 78 : 185 191.
14. Ballard JL, Eke CC, Bunt TJ, Killeen JD. A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems. J Vasc Surg 1995 22 : 485 490.
15. Lerman A, Burnett JC, Higano ST, McKinley LJ, Holmes DR Jr. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998 97 : 2123 2128.
16. Piatti P, Monti LD, Vaslecchi G et al. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in Type 2 diabetic patients. Diabetes Care 2001 24 : 875 880.
17. Bariş N, Erdoǧan M, Sezer E, Saygili F, Mert Ozgönül A, Turgan N et al. Alterations in L-arginine and inflammatory markers in type 2 diabetic patient with and without microalbuminuria. Act Diabetol 2009 46 : 309 316.
18. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999 48 : 1856 1862.